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ABSTRACT 
St. Jude Medical: ST Monitoring 
Anna Marie Kinney 
 
Myocardial infarction is the leading cause of death in the western world. Time is 
critical when treating patients with myocardial infarction. The major problem is that 
many patients who are symptomatic wait too long before seeking medical attention, and 
some patients have no symptoms at all. In order to improve patient outcome there needs 
to be a better way to diagnose myocardial infarction. One solution is the continuous 
monitoring of the ST-Segment of the intrinsic ventricular beat morphology, called the 
QRS complex. There have been many studies that show that there are detectable shifts of 
the ST-Segment during coronary occlusion. These shifts can be detected by implanted 
cardiac leads, like those used with implantable cardioverter defibrillators (ICD). The St. 
Jude Medical algorithm called ST Monitoring was designed to continuously monitor the 
ST-Segments and detect when there has been a significant shift. This thesis describes the 
implementation of the St. Jude Medical ST Monitoring algorithm on the St. Jude Medical 
Unity ICD platform. The process involved working on the requirements, design, 
implementation, and tests in order to verify the algorithm. The project was successfully 
completed and received FDA approval for an IDE study in the US and CE Marking in 
Europe. The data collected from the patients in the IDE will give confidence that the 
algorithm can successfully identify ST-Segment shifts that lead to myocardial infarction. 
If this is shown then the ST Monitoring algorithm can be used to reliably notify patients 
that they are having a significant cardiac event and need to seek medical attention 
immediately. 
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I. BACKGROUND AND CLINICAL IMPORTANCE 
Myocardial infarction, commonly known as a heart attack, is one of the leading 
causes of mortality in the western world. Myocardial infarction occurs when the blood 
supply to part of the myocardium is interrupted causing some of the cardiomyocytes to 
die. The coronary arteries supply the myocardium with the oxygenated blood that the 
heart needs to function [1]. When the coronary artery flow is restricted (see Figure 1) 
then the cardiomyocytes will not get the oxygen they need to function, and could die. As 
the cardiomyocytes die, the ability of the heart to pump blood throughout the body is 
impaired.  
 
Figure 1: Coronary Artery System [1] 
 
Early detection and prompt intervention of an acute myocardial infarction 
significantly improves the clinical outcome. The mean time from myocardial infarction 
symptom onset to arrival at a hospital for treatment is about 2.5 to 3 hours [2,3]. Surveys 
and focus groups of heart patients, family members, and the public report that they 
thought the presenting symptoms were less dramatic then expected. Many patients take a 
“wait and see” approach until they are more certain of the symptoms significance [4]. A 
large proportion of irreversible myocardial injury and fatal ventricular arrhythmias occur 
in the first several hours after closure of a coronary artery [2,3]. The longer the time 
between closure of the artery and the treatment lead to further myocardial necrosis and 
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worse clinical outcomes [3]. Treatment could include a defibrillation shock if the patient 
has an irregular heart arrhythmia, medication to help dissolve blood clots and open a 
blocked coronary artery, or a stent placement to open the blocked coronary artery. In 
order to improve upon the treatment of myocardial infarction there needs to be an easy 
and reliable way to diagnose the acute myocardial infarction. 
Myocardial infarction is an acute form of myocardial ischemia. Myocardial 
ischemia is a disorder caused by a critical coronary artery obstruction termed 
atherosclerotic coronary artery disease (CAD). Atherosclerosis occurs when fatty 
material and plaque build up on the walls of the artery. The buildup narrows the artery 
and the blood flow is decreased potentially leading to myocardial infarction. Myocardial 
ischemia may be temporary and reversible, or permanent and irreversible leading to 
myocardial infarction [5]. Myocardial ischemia can be temporary when there is brief 
periods of coronary occlusions followed by reperfusion, possibly in situations when the 
coronary blockage is not significant enough during normal conditions but as demand 
increases, for example with exercise, the blockage could become significant until the 
demand returns to normal. This has been termed myocardial stunning [5]. Reversible 
myocardial ischemia depends mostly on the amount of time the myocardial cells have 
been restricted of oxygen, the shorter the amount of time the better, from seconds to 
minutes. The damage becomes permanent and irreversible when the blockage is severe or 
the flow has been compromised for longer, from minutes to hours (see Figure 2).   
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Figure 2: General timeline of changes at onset of ischemia [5] 
 
Diagnosis of myocardial ischemia prior to a heart attack is important for optimal 
disease management. This year approximately 1.5 million Americans will have a heart 
attack resulting from myocardial ischemia, and 500,000 of those will be fatal. In one third 
of those patients, CAD is not diagnosed until after a heart attack occurs [6]. Treating 
known CAD is beneficial. Coronary artery revascularization, such as angioplasty, 
coronary artery bypass graft (CABG), or stent placement, and other medical therapies, 
such as medication, significantly reduce the morbidity and mortality rates of this disease. 
Therefore, early detection and diagnosis of CAD is critical. 
The diagnosis of CAD is difficult because in many cases the disease is not 
diagnosed until after the patient has had a heart attack. Some patients with CAD 
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experience symptoms such as unstable angina while others have no symptoms at all. This 
disease occurs in a range of patients, both the young and old, women and men, and in 
patients with and without co-morbidities [6]. There currently is not a uniformly accepted 
screening method for CAD but the most common forms of testing are treadmill, or stress 
testing, and for patients with moderate-to-high risk for CAD a cardiac imaging study. 
These tests, explained later, are looking for changes in the cardiac signal. 
Myocardial ischemia results in electrophysiological changes that are detectable. 
Within seconds of the onset of myocardial ischemia there are ventricular morphology 
changes, including ST segment changes, called an ST shift, which can be seen on a 
surface electrocardiography (EKG) [5,6,7] (See Figure 3). The ST segment is the portion 
of an electrocardiogram between the QRS complex (ventricular depolarization or R 
wave) and the beginning of the T wave (ventricular re-polarization) as seen in Figure 4.  
 
Figure 3: Surface EKG (ECG) of morphology changes due to occlusion [7] 
 
 
Figure 4: QRS Complex [6] 
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Myocardial ischemia impairs ventricular contraction and relaxation, therefore 
altering the ST segment. In general, the underlying cause of the ST shift is an altered ion 
transport across the myocardial cell membrane [5]. Measuring the ST segment deviation 
on the surface EKG, usually using a caliper-based technique or automated system, is the 
most common clinical technique for diagnosis of myocardial ischemia [7].  
Treadmill tests are used on patients with symptoms or signs of CAD and patients 
with significant risk of CAD. Surface EKG monitoring is used during treadmill tests to 
see if there are any morphology changes in the beat complex, such as ST changes, during 
exercise when the heart requires more oxygen. This type of test will indicate if the 
patient, who may have no symptoms at rest, has symptoms, such as pain in the chest or 
other areas in the upper body or changes seen the heart monitor, when the heart is 
stressed.  
Another method for detecting myocardial ischemia is with long-term 
electrocardiography recording using a Holter EKG monitor. A patient will wear the 
Holter EKG monitor (see Figure 5) with 3-4 electrodes placed on the body for 
approximately 24 hours to allow for long-term monitoring for ST segment changes. The 
leads are typically placed below the right and left clavicle and one on the lower chest. 
The placement may also depend on which coronary artery is involved. The continuous 
electrical signals are stored onto the device to be retrieved and analyzed by the physician 
later. Many holter devices now have accompanying software to help analyze the data. 
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Figure 5: Holter EKG Monitor from Cardio Labs [12] 
 
Holter EKG monitoring can help in detecting both symptomatic and 
asymptomatic, or silent, myocardial ischemia and is fundamental for characterizing 
episodes in patients with suspected or documented CAD [6,7]. Long-term monitoring is 
beneficial since studies have shown that some patients, particularly with angina, 
experience short myocardial episodes at night or in the morning. Therefore these patients’ 
treadmill tests are usually negative [8]. Holter EKG monitoring may reveal ischemia in 
about 10% of those with a negative treadmill test [9]. Holter EKG monitoring has also 
shown that episodes of subendocardial (occurring under the endocardial, the inner most 
layer of tissue, of the wall of the heart) ischemia have a typical circadian distribution with 
a first peak in the morning hours and a second peak in the afternoon [10]. Many studies 
have indicated that ischemia, even transient ischemia, on Holter EKG monitoring are 
among the major predictors of cardiac events in patients [6]. 
Practical application of long-term monitoring for ST segment deviations have 
been limited, due in part to the inconvenience of Holter EKG monitoring and the 
prevalence of false-positive ST segment deviations as a result of noise, postural changes, 
and artifacts [7]. Chronic ischemia monitoring would be very beneficial in documenting 
the reproducibility of the ischemic pattern since day-to-day episodes can be variable [6]. 
Also, early and reliable detection of myocardial ischemia would be clinically valuable if 
the result is an improvement of the time to treatment for patients [2,3,7].  
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Another approach to chronic monitoring of the ST segment deviations is to use 
intracardiac electrograms (IEGM) that are recorded by permanently implanted electrodes 
which are used for pacemakers and implantable cardioverter defibrillator (ICD) devices. 
IEGM avoid the insulating effects of the lungs and thorax due to the distance between the 
electrodes, giving a 5 to 10 times larger signal amplitude then a surface EKG. Noise and 
signal artifacts are also greatly reduced due to the lack of electrode-skin interfaces [7]. 
The location of the implanted electrodes is convenient, consistent, permanent, and 
capable of continuously monitoring of the ST segment using the IEGM. Indication for an 
ICD implant generally revolves around patients having or being ask risk for ventricular 
arrhythmias and about 50% of ICD patients either have documented CAD or are at risk of 
developing CAD [6,7]. Several studies have shown that cardiac ischemia can be detected 
from IEGM of an ICD and that the sensitivity of IEGM for detection of ischemia may be 
superior to that of surface EKG (see Figure 6) [2,3,7]. Another advantage of using 
implanted cardiac rhythm management devices is the ability to correlate ST segment 
changes with other cardiac events, such as ventricular arrhythmias. 
   
  8 
 
Figure 6: Comparison of IEGM and Surface EKG [2] 
 
The immediate benefit of chronic ST segment monitoring is the early 
confirmation of an acute coronary event or acute myocardial infarction in patients who 
have an implanted device. A second benefit is the potential to notify patients upon 
detection of a significant coronary event [3,6]. This could greatly decrease the amount of 
time between ischemia onset and treatment. Additionally, the monitoring of the ST 
segment provides the possibility of early intervention that could positively affect clinical 
outcomes in CAD patients who have changes in their ischemia profile over the course of 
their disease [6].   
It is for these reasons that St. Jude Medical developed the ST Monitoring 
algorithm on the ICD platform. The ICD platform was chosen because approximately 
50% of patients with an ICD have some form of CAD [6]. St. Jude Medical collaborated 
with Angel Medical Systems, Inc. on the initial algorithm for ST-segment analysis for 
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non-paced beats. Currently, no commercial device exists that is capable of chronically 
monitoring cardiac signals for the recording and detection of myocardial ischemia. 
An initial ST Monitoring algorithm was developed on the St. Jude Medical Epic 2 
ICD platform for research and evaluation purposes only in 2006. However the Epic 2 
platform, the hardware and software platform used for previous St. Jude Medical devices, 
is not in active production anymore. During preliminary algorithm evaluation research 
personnel at St. Jude Medical performed testing to characterize ST-segment changes 
associated with acute ischemia using data from canine tests [6]. The testing included the 
evaluation and recording of ST-segment changes during occlusion of various coronary 
locations within the heart. The canine study was designed to assess the algorithm 
behavior and to evaluate feature diagnostics.  
A chronic pig study was also performed to evaluate the chronic performance of 
the detection algorithm and diagnostics. In summary, six pigs were implanted with an 
ICD, one week following implant two copper stents per animal were placed in various 
coronary vessels. At the time of the stent implant, a balloon catheter was inflated in the 
coronary vessels to provoke ischemic changes on the IEGM. At the termination of the 
study, it was determined that the study design was not optimal for this project. The pigs 
were too small and the ICD lead implants caused significant trauma to the heart resulting 
in numerous ST-T wave abnormalities [6]. 
Clinical studies were also performed on the initial ST Monitoring algorithm to 
investigate various aspects of the cardiac signal related to chronic IEGM analysis of the 
ST-segment changes. One study evaluated the stability of the ST-segment during daily 
life activities and/or ST-changes during exercise. The results from this study showed that 
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there is a reasonable daily range of the ST shift allowing a threshold to be set to avoid 
false positives. It also showed that the proposed algorithm was only appropriate for 
intrinsic complexes. In another study, simultaneous recordings of IEGM and surface 
EKG were taking during a balloon angioplasty to compare changes during balloon 
occlusion and subsequent re-opening of coronary vessels. The results from this study 
showed poor correlation between the IEGM and surface EKG most likely due to the poor 
contact of the lead with the myocardium. Angel Medical Systems performed a similar 
study which resulted in very good correlation. In this study the lead was screwed well 
inside the myocardium which may account for the difference [6]. 
With the results of the studies conducted by St. Jude Medical, the studies 
conducted by others, and the apparent need for such an algorithm available on a marketed 
device St. Jude Medical decided to implement the ST Monitoring algorithm onto the next 
generation devices, called the Unity platform, that are now available as the AnalyST 
Accel™ family of ICDs which is the focus of this thesis.  
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II. PROJECT OBJECTIVE 
The objective of this thesis is to implement the algorithm as described by the St. 
Jude Medical research department in collaboration with Angel Medical Systems and 
described here. 
The St. Jude Medical ST Monitoring algorithm is a diagnostic algorithm 
implemented on the ICD platform that continuously monitors the IEGM for ST shifts. 
The ST Monitoring algorithm is implemented on the Unity device platform which has a 
dedicated IEGM filtered channel in the hardware of the device with a 0.33 Hz filter with 
sampling at 512 Hz for use by ST Monitoring. The filter characteristics determine the 
amount of data from the analog signal that is retained in the digital signal where a smaller 
frequency retains more data and the sampling frequency digitizes more of the data. If 
these characteristics are not optimized the signal will not be sufficient for detecting 
changes in the ST portion, as shown in preliminary testing with a 0.7 Hz filter [6]. The 
0.4 Hz filter characteristic was determined to be sufficient to analyze and detect ST shifts 
on the IEGM.  
The vector analyzed is from the tip of the lead in the right ventricular chamber to 
the can of the device, RV tip-to-Can (see Figure 7). The vector is the anode and cathode 
of the signal that is used to obtain the IEGM signal. This vector is used because it 
captures most of the ventricle. Changes in the IEGM signal will be detectable no matter 
where the ischemic injury may be or the direction of the signal shift (see Figure 8). 
Transmural injury occurs on the outside of the myocardium and sub-endocardial injury 
occurs on the inside cavity of the myocardium. 
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Figure 7: RV tip-to-Can Lead Configuration [11] 
 
 
 
 
Figure 8: RV tip-to-Can IEGM vector [6] 
 
Analysis of the ST-segment is done every 30 or 90 seconds by comparing the 
relative amplitude of the ST-segment portion to a reference window measured 
immediately prior to the R wave of the intracardiac signal. This relative ST-segment 
amplitude change is further normalized to the R peak in order to accommodate non-
physiological changes in amplitude of the intracardiac signal. Such changes might occur 
if the sensing lead is not stable within the ventricle or if the sensing vector changes due to 
variations of the patient’s body position. 
An intrinsic ventricular cardiac signal is monitored every 30 or 90 seconds for 
changes in the ST-segment. A set of cardiac beats consists of no more then 15 ventricular 
complexes. A ventricular complex is a ventricular event, either a ventricular paced beat 
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or a ventricular intrinsic beat, called QRS complex or R wave. The criteria of 6 out of 8 
beats are used to determine if a ST-shift occurs within the set being analyzed. For 
example, if 6 beats are measure as “shifted” before three “non-shifted” beats are analyzed 
the set is classified as “shifted”. The algorithm will wait until the next 30 or 90 second 
interval and re-evaluate the ventricular complexes. If three consecutive “shifted” sets are 
detected, the algorithm will consider this a ST episode. When sets are classified as “non-
shifted” the algorithm waits 90 seconds between analyzing sets. Once a set is classified as 
“shifted” the algorithm will analyze a set every 30 seconds. 
There are two levels of ST episodes that can be detected, minor ST episodes and 
major ST episodes, based on the degree of ST-shift. The distinction is made based on the 
ST-segment shift threshold which can be set independently as either a positive or 
negative shift. The threshold is a predefined value that the ST-shift value needs to exceed 
to be considered either a minor shift or a major shift. This will be explained in more 
detail later. There is also another type of minor ST episode called a persistent minor ST 
episode. If a minor ST episode is ongoing, meaning the ST-shift is greater then the minor 
threshold, for a period of time that exceeds a predefined “persistence time” the detection 
of a persistent minor ST episode will be triggered. An ST episode is terminated when two 
consecutive “non-shifted” sets occur.  
ST-Shifts can be determined because the current ST-segment being evaluated is 
compared to a baseline, non-shifted ST-segment. The algorithm performs baseline 
extraction once every six hours, called a time segment. A baseline set is a qualified 
reference of the patient’s normal, non-shifted rhythm. This qualified reference is used to 
determine how the patient’s current ST-Shift deviates from the non-shifted rhythm. 
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Baseline sets are averaged over the last three days and then are used to classify intervals 
in the same time segment, 24 hours later. If the signal shows a ST-shift when a baseline is 
attempted then the baseline can not be extracted at this time and the algorithm will need 
to wait until there is no ST-shift. 
As part of the ST Monitoring algorithm there are numerous diagnostics stored that 
will be expanded on in the next section. These diagnostics have been deemed important 
by the voice of customer interviews. The ST Monitoring algorithm stores other 
diagnostics that are being used internally by the Clinical and Systems Engineering 
department to evaluate the performance of the algorithm that will also be described on in 
the next section. 
The objective is to take the initial ST Monitoring algorithm that was for 
evaluation purposes that was described above and implement it on commercially 
available St. Jude Medical device. 
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III. DESIGN AND IMPLEMENTATION 
As part of the St. Jude Medical firmware development team my role for the ST 
Monitoring algorithm was to provide my knowledge on the Unity device platform for 
implementation. The process of design and development included requirements, design, 
implementation, and verification testing.  
The ST Monitoring, or STM feature was broken up into sub-features. ST 
Monitoring Controller (STMC) initializes the algorithm and controls when analysis will 
be performed. ST Monitoring Analysis (STMA) does the complex analysis and 
determines when a set is complete. ST Monitoring Baseline Extraction (STMB) extracts 
the non-shifted baseline set. ST Episode Detection (STME) determines the entry/exit 
criteria for a ST episode. ST Monitoring Stored IEGM (STMS) collects the IEGM signal 
for diagnostics. There are also diagnostic for ST-Segment data, Baseline data, and ST 
Episode data.  
The work in this thesis focuses on the design and implementation of the ST 
Monitoring feature as well as the process in order to implement the feature successfully. 
As a development engineer my portion of the project was to implement one of the ST 
Monitoring sub features, specifically ST Monitoring Controller, as well as participating 
in all other aspects of the feature implementation, as described here. Working on this 
feature required helping with requirements and verification testing. The requirements are 
used to fully specify how the software works. It was important that all engineers that 
work on a feature have the same understanding of the requirements. An initial part of 
developing a feature was to work with the requirements engineer to ensure the state of the 
requirements was satisfactory. The requirements specify all parameters and algorithm 
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behavior. An example of a requirement that specifies a parameter is for the ST 
Monitoring Mode. An example of a behavioral requirement is the definition of what a 
Good Interval is for ST Monitoring (see Figure 9). 
 
 
Figure 9: Requirement Example 
 
Once the requirements were complete then the firmware development engineer 
analyzed the requirements and designed how the feature works. The firmware 
development engineer decided how the implementation would flow and negotiated the 
interfaces between their feature and other features in the system. Once the design was 
complete the firmware development engineer implemented the design in C code. 
Firmware development engineers also test their code in two ways. Unit testing is a code 
base test that ensures the feature code executes as expected, and bench testing ensures the 
feature code runs correctly with the rest of the system on the hardware target. The amount 
of bench testing was determined by the firmware development engineering and can be 
simple manual test or tests developed on a framework that allows for automation. For the 
STM feature code the framework that allowed for automation testing was used. These test 
cases interfaced with the device and other test tools, such as a heart simulator, to generate 
known scenarios so that the device response could be determined to be correct. 
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Another part of working on a feature was to help the verification engineer write 
test scenarios. The verification engineer also had to fully understand the requirements in 
order to test the feature to make sure the implementation meets the requirements. It was 
important for the firmware development engineer to work with the verification engineer 
throughout the verification process. The verification engineer would find bugs, or errors, 
during testing which would need to be analyzed so having knowledge of how a test case 
was designed was helpful to the firmware development engineer when trying to 
determine what caused the error. The firmware development engineer also supports the 
code through all future projects. 
All firmware development engineers were key reviewers for the other sub-
features which required knowledge of how the sub-feature worked in order to provide 
feedback and ensure it was implemented correctly. During the development process there 
were many reviews that were performed. Firmware development engineers were involved 
in these reviews for other features. Such reviews include requirements, design, 
implementation, and verification reviews. It was also important to have knowledge of 
other features so that if the original firmware development engineer was not available, 
there are others that know how the feature works. This was particularly true for the ST 
Monitoring project because the original development engineers for the ST Monitoring 
Baseline Extraction, ST Episode Detection, and ST Monitoring Stored IEGM sub-
features left the company before the project was completed.  
In the next sections the design for each sub-feature is described. These designs 
were then implemented in software. The software matches the design exactly. 
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III.1 ST MONITORING CONTROLLER 
Section removed by St. Jude Medical legal. 
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III.2 ST MONITORING ANALYSIS 
Section removed by St. Jude Medical legal. 
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III.3 ST MONITORING BASELINE EXTRACTION 
Section removed by St. Jude Medical legal. 
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III.4 ST MONITORING EPISODE DETECTION 
Section removed by St. Jude Medical legal. 
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III.5 ST MONITORING STORED INTRACARDIAC ELECTROGRAMS 
ST Monitoring Stored IEGM (STMS) is a sub-feature of ST Monitoring. It 
provides IEGM data, markers and timestamps to be retrieved and displayed on the 
external instrument so that the clinician can examine the ST Segment variations. STMS 
stores IEGM data for baseline sets and specific sets when an ST Episode occurs. The four 
most recent successful baseline sets and the four most recent unsuccessful baseline sets 
are stored. When an ST Episode is detected the IEGM data of the baseline set that was 
referenced by STMA to determine the ST Shift is saved as well as the entry set and the 
set that contains the maximum ST Shift during the ST Episode.  
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III.6 ST MONITORING STORED DIAGNOSTICS 
The IEGM data is part of the diagnostics that is gathered by the ST Monitoring 
algorithm. There are many diagnostics the ST Monitoring algorithm collects. These 
diagnostics are intended to help the physician make informed decisions as a patients 
disease progresses. The ST Monitoring algorithm collects data on the ST Deviations that 
are analyzed. Every single ST Deviation the algorithm calculates is stored into a daily 
histogram which consists of bins with a specified ST Deviation range for each heart rate 
zone for each day. After the ST Deviation is determined for a good beat the histogram bin 
that corresponds to the day, heart rate zone, and ST Deviation value for this beat is 
incremented by one. ST Deviation from the most recent seven days is also stored (see 
Figure 10).  
 
Figure 10: ST Deviation Histograms 
 
At the end of each 24 hour period, or day, the ST Deviation Daily Trend is 
updated. The daily trend holds the minimum, maximum, and mode (most frequent) ST 
Deviation from the current day for each heart rate zone. Again, there are seven days of 
trend data stored. Similarly there is a ST Deviation Weekly Trend that holds the 
minimum, maximum, and mode ST Deviations for each heart rate zone for the week. The 
weekly trend holds up to six months of data (see Figure 11). 
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Figure 11: ST Deviation Weekly Trend 
  
The ST Monitoring algorithm also stored diagnostics associated with the baseline 
sets that are extracted. Some of these diagnostics are for the clinician to see and some are 
for research purposes only and are not displayed to the clinician. The baseline diagnostics 
that are available on the display are associated with the four baselines, one for each six 
hour time segment, which include the IEGM data as well as the average ST Deviation 
and average R peak for the baseline set (see Figure 12). The research diagnostics that are 
collected by the device are the four most recent unsuccessful baselines diagnostic, the 
unsuccessful baseline failure reason counters, the raw baseline log, the Quick-
Initialization counter, and the paced set diagnostics. The unsuccessful baseline diagnostic 
includes the IEGM data and failure reason for the most recent four unsuccessful baseline 
extractions. The reasons for failure listed in the unsuccessful baseline diagnostic also 
have counters. The device keeps track of how many times a baseline fails for one of four 
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reasons, excess shift, high heart rate zone, saturated R waves, and non-classified beats. 
Baseline extraction could fail due to the ST Shift being too high or the heart rate of the 
set is too high. Also, if the R wave amplitude value is too high or too low the baseline 
extraction will fail. The last reason occurs when there are too many bad beats in a set, due 
to PVC beats or paced beats. 
 
Figure 12: ST Baseline IEGM data 
 
Another diagnostic associated with baselines is the raw baseline log. The result of 
baseline extraction for each time segment for the last 100 days is stored. When a baseline 
set is extracted for a segment the timestamp, ST Deviation, and R peak of the successful 
baseline is stored. If baseline extraction is unsuccessful for a segment the timestamp, ST 
Deviation, and R peak are stored for the set that was the first attempt of the segment. If 
baseline extraction was not allowed for a segment, possibly due to an interaction or ST 
Episode ongoing, then the log is updated with a timestamp and values that indicate there 
was no baseline extraction attempted. 
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The last of the research diagnostics are the Quick-Initialization counter and the 
paced set diagnostics. The Quick-Initialization counter is updated every time Quick-
Initialization occurs. The paced set diagnostics is a 100 day log. Each entry represents a 
day and holds the total number of sets analyzed and the number of those sets that 
included at least one paced event. 
The ST Monitoring algorithm also stores diagnostics associated with ST 
Episodes. There are three ST Episode logs, Major Episode, Persistent Minor Episode, and 
Minor Episode. Each log holds the same type of information (see Figure 13). There is a 
counter for the total number of ST Episodes for that type. There is a timestamp for when 
the ST Episode was entered and exited, which is used to calculate the duration of the ST 
Episode. The interval average of the rhythm prior to the entry set and the average ST 
Shift of the entry set are recorded. The average R peak of the reference baseline set that 
was used to determine the ST Shift is recorded. The interval average of the rhythm prior 
to the set with the max ST Shift and the average ST Shift of the set with the max ST Shift 
are recorded. Lastly the reason for the episode to exit is recorded, including non-detect 
sets detected, non-classified sets detected, critical interaction terminated, episode 
exceeded three days, or Minor/Persistent Minor exited due to Major ST Episode detected. 
As mentioned before, each ST Episode has three sets of IEGM data associated with it, the 
reference baseline data, the entry set data, and the max ST Shift set data (see Figure 14). 
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Figure 13: ST Episode Log 
 
 
Figure 14: ST Episode Detection 
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IV. RESULTS 
During feature implementation each development engineer, including myself, was 
responsible for testing their feature. This included input/output unit testing run in the 
development environment and bench testing run on the hardware target. Running these 
tests gives the development team a chance to find and fix problems before formal 
verification tests are done by the Verification test engineers. All unit testing and bench 
tests must have passing results before the feature can be considered complete. The ST 
Monitoring algorithm successfully passed all unit and bench testing. The unit test concept 
is to execute every single line of code with known inputs to ensure that the output from 
the code is correct. The granularity of the code tested can vary from one single function 
to a flow of functions. The purpose is to ensure that the code executed as development 
engineer expected. Examples of unit tests for the STM feature are checking that when the 
program parameter for ST Monitoring Mode (as seen in Figure 9) is set to ON and the 
programming function is called, that the correct state is entered, see 
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APPENDIX B for this example. The feature is required to have every single line of code 
covered by at least one unit tests, i.e. have 100% code coverage, and all unit tests need to 
pass (see 
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APPENDIX C for examples of the output). The other, less formal form of testing was 
bench testing. The amount of bench testing done was up to the development engineer, as 
well as the method of testing. For STMA, STMB, and STMC automated tests were 
developed which allowed the same tests to be run at any time. These bench tests have a 
similar concept to unit tests where the tests start with a known input then the feature is 
ran with a known scenario and the output is tested. Most of the bench tests revolve 
around a known cardiac event sequence, for example (see
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APPENDIX D) the R wave amplitude value that is known is ran through the gain 
algorithm to test that the correct gain setting is selected. Another example would be the R 
wave with a known ST-shift is the input to the episode detection algorithm to test that the 
ST episode is entered correctly.  
Once the firmware development team had confidence that the algorithm was 
working correctly the other teams executed their own tests on the algorithm. The ST 
Monitoring algorithm was verified against the requirement specification to prove that the 
algorithm ran as specified by the Verification team. Another level of testing was done by 
the Clinical and System team. The clinical and system engineers ran tests on the whole 
system, the device plus the external instrument, to ensure that all diagnostics collected by 
the device were displayed correctly to the clinician. The system engineers also do animal 
testing to see how the algorithm handles real data. The testing done by the other teams 
are beyond the scope of this thesis, but the ST Monitoring algorithm needed to pass all 
levels of testing, unit, bench, verification, and clinical and system testing to be considered 
complete. All levels of testing resulted in passing marks for the algorithm and the device 
was sent to the Food and Drug Administration (FDA) and European Union for approval 
for human use. The ST Monitoring algorithm is available on St. Jude Medical devices 
called AnalyST. The AnalyST device has been approved by the FDA for an 
Investigational Device Exemption (IDE) study, which is still being developed by the 
System and Clinical team, and has been given the CE marking for use in Europe. 
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V. DISCUSSION 
Since the device has received approval for human use St. Jude Medical is 
collecting all the diagnostic data the device is storing to support the concept that the ST 
Monitoring algorithm can successfully identify when an ischemic event is occurring. 
There has been extensive research done to show that ST-Segment deviations can be 
detected by an ICD type device. The AnalyST device will be the first ICD device in use 
that will attempt to characterize ST-Segment deviations and determine when a patient is 
having an ischemic episode. Also, since the AnalyST device is an ICD the diagnostics 
collected by the ST Monitoring algorithm as well as other algorithms will be able to 
correlate ST Episodes with other cardiac events, such as Ventricular Tachyarrhythmia 
episodes.  
The AnalyST device has a patient notification system that can alert the patient 
when critical events in the device occur. These alerts inform the patient to seek medical 
attention immediately by vibrating the device. The ST Monitoring algorithm has a similar 
alert for when a Major ST Episode is detected. This feature is currently ‘locked out’ and 
is not available. It was implemented so that as clinical confidence grows that the 
algorithm is capable of detecting ST-Segment deviations that are critical cardiac events, 
then the patient notification for these events can be ‘turned on’. This will then allow 
patients an opportunity to seek medical attention prior to an ischemic myocardial 
infarction. 
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VI. CONCLUSION AND FUTURE WORK 
The ST Monitoring algorithm available on the AnalyST device is the first ICD 
device available in the market place that does continuous ST-Segment monitoring. The 
ST Monitoring algorithm was successfully implemented on the Unity device platform. It 
received FDA approval for an IDE study and the CE Marking for use in Europe. The 
diagnostics stored by the devices in use will be collected and analyzed by the Clinical and 
System Engineering department to determine the accuracy and effectiveness of the 
algorithm.  
The ST Monitoring algorithm was originally developed for ICD devices. There is 
work being done by St. Jude Medical that will also include the ST Monitoring algorithm 
on pacemaker devices. This will allow more data to be collected to support the IDE 
study. Although pacemaker patients may not have as high a risk for myocardial 
infarction, they can have or can develop CAD. Having the ST Monitoring algorithm 
available for these patients will help their physicians manage their disease progression. 
As more data becomes available the current high level algorithm design will be 
evaluated to see what is working and what may not be working. In the future the 
algorithm may be optimized.  
The ST Monitoring algorithm should be a great asset to the features available on 
St. Jude Medical devices. Such innovative technologies provide St. Jude Medical with the 
opportunity to present itself as a market leader for patient care. Algorithms like ST 
Monitoring also vastly improve individual patient care by providing an early warning 
system that something is wrong. This would allow patients to seek medical treatment 
early so intervention will likely be more successful and less costly. 
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